Woodcock Faces Maze Of Rules To Become Commissioner Nominee

If Biden administration wants to nominate the acting commissioner, Vacancies Reform Act would dictate the timing. Woodcock can still get the nod and remain head of the agency during the confirmation process, just as Andrew von Eschenbach retained his acting title following his nomination in 2006.

Since Woodcock is already acting commissioner, the Biden administration has a more complicated path to follow if it wants to nominate her to the position permanently.

More from US FDA

More from Agency Leadership